Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials†.
Umberto Benedetto, Shahzad G Raja, Alberto Albanese...
https://pubmed.ncbi.nlm.nih.gov/24686003/Actively Recruiting
Led by Weill Medical College of Cornell University · Updated on 2026-08-20
4300
Participants Needed
59
Research Sites
52 weeks
Total Duration
Researchers are evaluating the use of one versus multiple arterial grafts in patients undergoing primary isolated non-emergency coronary artery bypass surgery CABG. This international, randomized trial aims to determine if multiple arterial grafts reduce a combined outcome of death, stroke, heart attack after discharge, or repeat revascularization, compared to a single arterial graft. The study also seeks to assess if multiple arterial grafts improve overall survival in these patients with coronary artery disease. Participants are randomly assigned to receive either a single arterial graft, which is the left internal thoracic artery plus venous grafts, or multiple arterial grafts including the left internal thoracic artery plus a second arterial graft such as the right internal thoracic artery or radial artery. Some patients in the multiple graft group may receive additional arterial grafts. This trial enrolls at least 4,300 patients across 25 international centers and uses a 11 randomization with stratification by center and graft type. During the study, participants will be monitored for outcomes including death, stroke, myocardial infarction, and repeat revascularization starting more than 72 hours after surgery. Additional assessments include 30-day mortality, postoperative complications, sternal wound healing, and hospital readmissions. Follow-up analyses will evaluate survival and cause-specific mortality over an average of 5 years. The study is expected to continue until 2030, with comprehensive safety and effectiveness monitoring throughout.
CONDITIONS
Randomization of Single vs Multiple Arterial Grafts
M
Mario Gaudino, MD
M
Marshagay Rodriques
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Multiple arterial grafting | Single arterial grafting |
|---|---|---|
| What it is | CABG using left internal thoracic artery plus a second arterial graft (right internal thoracic or radial) in addition to venous grafts | CABG using left internal thoracic artery plus venous grafts (single arterial plus vein) as defined in the trial |
| Role in trial | Investigational experimental arm | Comparator/control arm in the randomized study |
| Primary use | To assess whether adding a second arterial graft improves outcomes in CABG | To compare outcomes of standard single arterial plus venous CABG |
| How it is performed | Left internal thoracic artery to left anterior descending plus second arterial conduit (right internal thoracic or radial) for other targets | Left internal thoracic artery to left anterior descending artery plus venous grafts for other targets |
| Evidence status | Meta-analyses and observational studies suggest multiple arterial grafts may improve long-term survival and reduce repeat interventions | Long-standing established technique with registry and guideline support for single arterial graft outcomes |
| Important risks | Possible increased risk of operative complexity and sternal wound infection especially with bilateral internal thoracic arteries | Risks typical of CABG surgery including sternal wound complications and operative risks |
| Important limitations | Technique is surgically more complex and evidence largely observational or meta-analytic pending definitive trial results | May have lower long-term durability compared with multiple arterial conduits |
| Patient impact | May offer better long-term survival and lower need for repeat procedures compared with single grafting | Standard surgical strategy; provides reliable symptom relief and survival consistent with decades of practice |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single surgery event
Participants undergo coronary artery bypass surgery receiving either a single arterial graft or multiple arterial grafts as assigned by randomization.
Hospital stay and regular post-operative assessments up to 30 days
Duration - Up to 5 years
Participants are monitored for clinical outcomes including death, stroke, heart attack, repeat procedures, and post-operative complications for an average of 5 years.
Periodic follow-up visits and assessments
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Umberto Benedetto, Shahzad G Raja, Alberto Albanese...
https://pubmed.ncbi.nlm.nih.gov/24686003/F D Loop, B W Lytle, D M Cosgrove...
https://pubmed.ncbi.nlm.nih.gov/3484393/Giuseppe Nasso, Roberto Coppola, Raffaele Bonifazi...
https://pubmed.ncbi.nlm.nih.gov/19379973/David P Taggart, Douglas G Altman, Alastair M Gray...
https://pubmed.ncbi.nlm.nih.gov/27959712/Renato D Lopes, Rajendra H Mehta, Gail E Hafley...
https://pubmed.ncbi.nlm.nih.gov/22238227/Gijong Yi, Brian Shine, Syed M Rehman...
https://pubmed.ncbi.nlm.nih.gov/24916209/Jay Shavadia, Colleen M Norris, Michelle M Graham...
https://pubmed.ncbi.nlm.nih.gov/26027621/Mario Gaudino, John D Puskas, Antonino Di Franco...
https://pubmed.ncbi.nlm.nih.gov/28119382/Patrick W Serruys, Andrew T L Ong, Lex A van Herwerden...
https://pubmed.ncbi.nlm.nih.gov/16098418/Gabriel S Aldea, Faisal G Bakaeen, Jay Pal...
https://pubmed.ncbi.nlm.nih.gov/26680310/Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor